Search Result for 'cellets'

In the realm of pharmaceutical formulations, the quest for efficient and reliable drug delivery systems has led to significant advancements. ...

challenges: dose‑dumping in the presence of alcohol, variable pharmacokinetics depending on food intake, and patient inconvenience. To address these issues, ...

to optimize GHB’s absorption, enhancing patient convenience and compliance by reducing the need for multiple nightly doses. The key innovation ...

time. The goal is to provide 6 to 8 hours of sleep with just one bedtime dose. A key aspect ...

without altering their dosage or efficacy. The patent emphasizes how DVP affects GHB’s pharmacokinetics, allowing adjustments to minimize side effects ...

The following patent on “Extended-release compositions comprising atomoxetine” employs CELLETS® as starter spheres made of Microcrystalline Cellulose. Please, read below ...

The following patent on “Extended release compositions comprising pyridostigmine” employs CELLETS® as starter spheres made of Microcrystalline Cellulose. Please, read ...

such as capsules, tablets, or sachets. The flexibility of the dosage forms makes it easier to control and adjust the ...

make GHB therapy more convenient by eliminating the need for a second nightly dose and addressing the stability challenges that ...